Himachal Pradesh govt extends night curfew in Shimla, Mandi, Kangra, Kullu districts

▴ Himachal Pradesh govt extends night curfew in Shimla, Mandi, Kangra, Kullu districts

Himachal Pradesh government has extended the existing night curfew in Shimla, Mandi, Kangra, and Kullu districts, till the 5th of next month, in order to contain the spread of the COVID-19 pandemic.

Himachal Pradesh government has extended the existing night curfew in Shimla, Mandi, Kangra, and Kullu districts, till the 5th of next month, in order to contain the spread of the COVID-19 pandemic.

The decision to extend the curfew was taken in a state cabinet meeting chaired by Chief Minister Jai Ram Thakur in Shimla today.

The curfew will remain imposed in these districts from 9 pm to 6 am.

It may be recalled that earlier, the state government had decided to impose a night curfew from November 23 to December 15.

Meanwhile, the state registered 12 more COVID-19 fatalities today, taking the death toll in the state to 813.

While 676 patients were also recovered from the disease today, taking the total number of recoveries to 41954.

The total infection count of the state stands at 49761.

Tags : #India #HimachalPradesh #Shimla #Mandi #Kangra #Kullu #nightcurfew #Covid-19Pandemic #Covid-19Deaths #CoronaVirus #Curfew #DailyCovidUpdates

18 Jun	FDA approves nasal antihistamine for nonprescription use Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies. View
23 Dec	Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain View
18 Dec	Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals. View
07 Oct	Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera View
18 Aug	Glenmark appoints Dipankar Bhattacharjee to its Board of Directors Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization View
30 Jul	Food Allergies: All that you have to know Skin prick testing can in some cases produce bogus negative or bogus positive outcomes. View
21 May	Cipla receives final approval for Migranal Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation View
12 May	Hikma Announces the Launch of Propofol Injectable Emulsion, USP Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US View
28 Feb	Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US. View

Trending Now
	The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
	KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
	Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
	CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
	World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
	From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
	Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
	CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
	High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
	DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
	Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
	Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
	University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
	Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
	Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
	Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
	Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
	Prioritize your health during the holy days of RamzanMarch 31, 2025
	Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
	Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025